195 related articles for article (PubMed ID: 29026202)
1. Loss of ABHD5 promotes the aggressiveness of prostate cancer cells.
Chen G; Zhou G; Aras S; He Z; Lucas S; Podgorski I; Skar W; Granneman JG; Wang J
Sci Rep; 2017 Oct; 7(1):13021. PubMed ID: 29026202
[TBL] [Abstract][Full Text] [Related]
2. Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5.
Mitra R; Le TT; Gorjala P; Goodman OB
BMC Cancer; 2017 Sep; 17(1):631. PubMed ID: 28877685
[TBL] [Abstract][Full Text] [Related]
3. Loss of abhd5 promotes colorectal tumor development and progression by inducing aerobic glycolysis and epithelial-mesenchymal transition.
Ou J; Miao H; Ma Y; Guo F; Deng J; Wei X; Zhou J; Xie G; Shi H; Xue B; Liang H; Yu L
Cell Rep; 2014 Dec; 9(5):1798-1811. PubMed ID: 25482557
[TBL] [Abstract][Full Text] [Related]
4. The ATGL lipase cooperates with ABHD5 to mobilize lipids for hepatitis C virus assembly.
Vieyres G; Reichert I; Carpentier A; Vondran FWR; Pietschmann T
PLoS Pathog; 2020 Jun; 16(6):e1008554. PubMed ID: 32542055
[TBL] [Abstract][Full Text] [Related]
5. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
Zhang YP; Liu KL; Yang Z; Lu BS; Qi JC; Han ZW; Yin YW; Zhang M; Chen DM; Wang XW; Li W; Xin H
Cell Cycle; 2019 Oct; 18(19):2432-2446. PubMed ID: 31448674
[TBL] [Abstract][Full Text] [Related]
6. Molecular Basis of ABHD5 Lipolysis Activation.
Sanders MA; Zhang H; Mladenovic L; Tseng YY; Granneman JG
Sci Rep; 2017 Feb; 7():42589. PubMed ID: 28211464
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
[TBL] [Abstract][Full Text] [Related]
8. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
[TBL] [Abstract][Full Text] [Related]
9. ABHD5 suppresses cancer cell anabolism through lipolysis-dependent activation of the AMPK/mTORC1 pathway.
Chen G; Zhou G; Lotvola A; Granneman JG; Wang J
J Biol Chem; 2021; 296():100104. PubMed ID: 33219129
[TBL] [Abstract][Full Text] [Related]
10. Interactions of perilipin-5 (Plin5) with adipose triglyceride lipase.
Granneman JG; Moore HP; Mottillo EP; Zhu Z; Zhou L
J Biol Chem; 2011 Feb; 286(7):5126-35. PubMed ID: 21148142
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
Sun B; Fan Y; Yang A; Liang L; Cao J
J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA cMras Suppresses the Progression of Lung Adenocarcinoma Through
Zhou Q; Sun Y
Cancer Biother Radiopharm; 2023 Jun; 38(5):336-346. PubMed ID: 32822232
[No Abstract] [Full Text] [Related]
13. miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells.
Liu C; Guan H; Wang Y; Chen M; Xu B; Zhang L; Lu K; Tao T; Zhang X; Huang Y
PLoS One; 2015; 10(12):e0144073. PubMed ID: 26650737
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness.
Bizzarro V; Belvedere R; Migliaro V; Romano E; Parente L; Petrella A
Cell Adh Migr; 2017 May; 11(3):247-260. PubMed ID: 27834582
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
[TBL] [Abstract][Full Text] [Related]
16. Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression.
Hu J; Tian J; Zhu S; Sun L; Yu J; Tian H; Dong Q; Luo Q; Jiang N; Niu Y; Shang Z
Br J Cancer; 2018 Jan; 118(1):88-97. PubMed ID: 29123266
[TBL] [Abstract][Full Text] [Related]
17. Critical roles for α/β hydrolase domain 5 (ABHD5)/comparative gene identification-58 (CGI-58) at the lipid droplet interface and beyond.
Brown AL; Mark Brown J
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Oct; 1862(10 Pt B):1233-1241. PubMed ID: 28827091
[TBL] [Abstract][Full Text] [Related]
18. SPP1 Promotes Enzalutamide Resistance and Epithelial-Mesenchymal-Transition Activation in Castration-Resistant Prostate Cancer via PI3K/AKT and ERK1/2 Pathways.
Pang X; Zhang J; He X; Gu Y; Qian BZ; Xie R; Yu W; Zhang X; Li T; Shi X; Zhou Y; Cui Y
Oxid Med Cell Longev; 2021; 2021():5806602. PubMed ID: 34721759
[TBL] [Abstract][Full Text] [Related]
19. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN.
Duan XM; Liu XN; Li YX; Cao YQ; Silayiding A; Zhang RK; Wang JP
Kaohsiung J Med Sci; 2019 Nov; 35(11):659-671. PubMed ID: 31332950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
